| Ma Adriana T Custodio-pangilinan, RPH | |
|
47900 Washington St, La Quinta, CA 92253-2209 | |
| (760) 771-1526 | |
| (760) 771-1774 |
| Full Name | Ma Adriana T Custodio-pangilinan |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 47900 Washington St, La Quinta, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396028718 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | CA41606 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ma Adriana T Custodio-pangilinan, RPH 47900 Washington St, La Quinta, CA 92253-2209 Ph: (760) 771-1526 | Ma Adriana T Custodio-pangilinan, RPH 47900 Washington St, La Quinta, CA 92253-2209 Ph: (760) 771-1526 |
News Archive
Scientists at Schepens Eye Research Institute have found that when the eye is missing a diffusible form of vascular endothelial growth factor (VEGF), i.e. one that when secreted can reach other cells at a distance, the retina shows defects similar to "dry" macular degeneration, also called geographic atrophy (GA).
Enobia Pharma today announced positive data from a clinical study of ENB-0040, a bone targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). After six months of treatment with ENB-0040, four of five severely affected patients showed marked improvements in bone mineralization, correction of skeletal defects, better respiratory function, including weaning from assisted ventilation, and cognitive and motor development.
Janssen R&D Ireland (Janssen) announced today that two Phase 3 trials are recruiting patients to examine the efficacy and safety of the NS3/4A protease inhibitor simeprevir in combination with the nucleotide inhibitor sofosbuvir for the treatment of chronic genotype 1 hepatitis C virus (HCV) infection in treatment-naive and treatment-experienced patients with and without cirrhosis.
IL-7, a hormone-like protein involved in cell-cell interaction, has been associated with increased survival and expansion of T-cell acute lymphoblastic leukaemia (T-ALL).
A large percentage of patients with mild-to-moderate asthma have persistently non-eosinophilic disease which may not respond to currently available anti-inflammatory treatments, according to a new study.
› Verified 6 days ago
Larry Selkow, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 55104 Oak Tree, La Quinta, CA 92253 Phone: 760-702-0694 | |
Dr. Thien Van Vu Vo, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 78271 Highway 111, La Quinta, CA 92253 Phone: 760-564-2225 Fax: 760-564-8791 | |
Sipan Keshishyan, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 44075 Jeffeson St, La Quinta, CA 92253 Phone: 760-772-2969 | |
Thomas Majors, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 77925 Desert Dr, La Quinta, CA 92253 Phone: 858-922-3852 | |
Mr. Joseph Thomas Gualano, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 78-630 Highway 111, La Quinta, CA 92253 Phone: 760-771-9999 Fax: 760-771-9991 | |
Hannah Ethel Mason, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 52265 Rosewood Ln, La Quinta, CA 92253 Phone: 661-733-2908 | |
Robert Siskin, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 79120 Fox Run, La Quinta, CA 92253 Phone: 442-400-3213 |